Biotech

All Articles

FDA areas Kezar lupus test in hold following 4 person deaths

.The FDA has actually placed Kezar Lifestyle Sciences' lupus test on hold after the biotech flagged ...

Phase 3 Academic Rock test strikes SMA objective, sending out stockpile 200%

.A stage 3 test of Intellectual Stone's back muscular atrophy (SMA) candidate has actually attacked ...

CAMP 4 is actually most recent to eye IPO, while Upstream define $182M plan

.RNA biotech CAMP4 Therapeutics has actually marked out plans for a $67 million IPO, with inflammati...

Galecto acquires leukemia medicine, loses bone tissue cancer property in pivot

.A year after the failing of an idiopathic lung fibrosis prospect sent Galecto on a look for salvati...

Judo throws down $100M to knock senseless renal condition

.Taking the floor covering is Judo Bio, an up-and-coming biotech armed with $one hundred million to ...

AstraZeneca spends CSPC $100M for preclinical cardiovascular disease drug

.AstraZeneca has actually settled CSPC Pharmaceutical Group $one hundred million for a preclinical c...

Zephyrm finds Hong Kong IPO to fund phase 3 cell treatment trials

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock exchange, submission (PDF) for an...

Frazier Life Sciences gathers $630M for small, mid-cap biotechs

.Frazier Life Sciences has sourced an even further $630 thousand for its own fund focused on small a...

GigaGen garners around $135M BARDA bucks to hammer botox

.Antitoxin aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its tech to ...

GPCR organization Septerna files for IPO on strength of preclinical data

.Septerna is about to discover exactly how a biotech without "any purposeful medical records" meals ...